Capital Export to acquire a majority stake in Science & BioMaterials.

Financials

Edit Data

Transaction Value-

Consideration TypeCash

Capital Owned-

Capital Bid For-

EV/Sales-

EV/EBITDA-

Share Price Premium-

One Off Charge-

target

Science & Biomaterials

bidder

Capital Export

Sources

Edit

Tags

Edit

Acquisition

orthopaedic products

Friendly

Domestic

Single Bidder

Majority

Pending

Medical Equipment

Private

Private Equity

France

Synopsis

Edit

Capital Export, a venture capital and private equity firm, agreed to acquire a majority stake in Science & BioMaterials, an orthopedic surgery equipment maufacturer. Financial terms were not disclosed.

Capital Export to acquire a majority stake in Science & BioMaterials.

target

bidder

financial advisors